Roy C. Hardiman's Net Worth

$13 Million

Estimate Recalculated Sep 8, 2024 07:20PM EST

Who is Roy C. Hardiman?

Roy C. Hardiman has an estimated net worth of $13 Million. This is based on reported shares across multiple companies, which include Principia Biopharma Inc., PHARMACYCLICS INC, and ALUMIS INC..

SEC CIK

Roy C. Hardiman's CIK is 0001506218

Past Insider Trading and Trends

2024 was Roy C. Hardiman's most active year for acquiring shares with 7 total transactions. Roy C. Hardiman's most active month to acquire stocks was the month of June. 2020 was Roy C. Hardiman's most active year for disposing of shares, totalling 16 transactions. Roy C. Hardiman's most active month to dispose stocks was the month of August. 2020 saw Roy C. Hardiman paying a total of $76,556.53 for 70,000 shares, this is the most they've acquired in one year. In 2020 Roy C. Hardiman cashed out on 318,314 shares for a total of $12,824,621.68, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Principia Biopharma Inc. No price found

Chief Business Officer

Roy C. Hardiman used to own units in Common Stock but no longer holds any shares there.acquired a total of 20,000 shares in Principia Biopharma Inc. at a cost of $101,299.69, Roy also disposed a total of 137,761 shares of Principia Biopharma Inc. equalling to $13,071,655.53.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-119.68K
$100.00
-$11,967,700.00
0
Sep 28
Form 4
—
0
$52.92
-$470,596.97
117.76K
Scheduled
Sep 18
Form 4
—
0
$32.94
-$282,170.38
117.76K
Scheduled
Jun 12
Form 4
—
0
$26.64
-$219,197.80
116.9K
Scheduled
Mar 13
Form 4
—
0
—
—
0
Mar 5
Form 4
—
0
$27.18
-$222,290.71
120.14K
Scheduled
Dec 13
Form 4
—
0
—
—
0
Mar 1
Form 3
—
0
—
—
0
No matching records found

PHARMACYCLICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 1
Form 4
—
0
—
—
0
Jul 2
Form 4
—
0
—
—
0
Apr 2
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
—
—
0
Oct 3
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Dec 9 - Dec 13
Form 3
—
0
—
—
0
No matching records found

ALUMIS INC. No price found

Chief Business & Legal Officer

Roy C. Hardiman owns 175,401 units of Common Stock. Roy C. Hardiman used to own units in Class A Common Stock but no longer holds any shares there. In the year 2024 Roy C. Hardiman filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
181.82K
Jul 1
Form 3
—
0
—
—
0
No matching records found